XORTX Therapeutics Inc. Common Stock (XRTX) is a publicly traded Healthcare sector company. As of May 19, 2026, XRTX trades at $2.53 with a market cap of $4.01M and a P/E ratio of 0.00. XRTX moved +0.00% today. Year to date, XRTX is -8.77%; over the trailing twelve months it is -51.40%. Its 52-week range spans $1.73 to $12.55. Rallies surfaces XRTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
XORTX Therapeutics Closes US$5M Offering with 183,577 Shares and 2.48M Warrants: XORTX Therapeutics closed a US$5 million public offering by issuing 2,659,574 units—183,577 common shares and 2,475,997 pre-funded warrants—at US$1.88 each. Net proceeds will fund working capital, corporate activities and US$2.5 million for investor relations marketing, pending TSXV approval.
| Metric | Value |
|---|---|
| Price | $2.53 |
| Market Cap | $4.01M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $12.55 |
| 52-Week Low | $1.73 |
| Volume | 3.33K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
XRTX analyst coverage data. Average price target: $0.00.